• Skip to primary navigation
  • Skip to main content
  • Skip to footer
  • Biblioteca
  • Museu
  • Pessoal
    • Webmail
    • Área de Docentes
    • Área de Não-Docentes
  • Estudantes
    • Webmail
    • Moodle
    • NetP@
    • Escola Doutoral
    • Serviços Académicos
    • Trabalhar no IHMT

IHMT

Instituto de Higiene e Medicina Tropical

  • O Instituto
    • Missão
    • Mensagem do Diretor
    • Órgãos de governo
    • Docentes e investigadores
    • Portal de Denúncias UNL
  • Ensino
    • Mestrados
    • Doutoramentos
    • Cursos de Especialização
    • Formação transversal
    • Cursos de Curta Duração
    • Ensino à Distância
    • Apoio ao Desenvolvimento
    • Serviços académicos
    • NOVA Open Academy
  • Investigação
    • Centro GHTM
    • Unidades de Ensino e de Investigação (UEI)
      • Unidade de Clínica Tropical
      • Unidade de Microbiologia Médica
      • Unidade de Parasitologia Médica
      • Unidade de Saúde Pública Global
      • Serviço de Apoio à Ciência e Comunidade
    • Biobanco
    • BLOODless
    • Centro Colaborador OMS
    • Publicações
  • Serviços e gestão
    • Biblioteca
    • Sistema de Qualidade
    • Estatutos e regulamentos
    • Plano de Atividades
    • Relatório de Atividades
    • Relatório de Gestão
    • Contratos públicos
    • Recursos humanos
      • Concursos e bolsas
        • Concursos – Docentes e Investigadores
        • Concursos – Não Docentes e Não Investigadores
        • Bolsas de Investigação
      • Contratos
      • Avaliação de Desempenho
        • Ciclo Avaliativo
          • Biénio 2021-2022
          • Biénio 2023-2024
        • Conselho Coordenador de Avaliação
        • Comissão Paritária
      • Mobilidade
      • Listas Nominativas
  • Doenças Tropicais
    • Consulta do Viajante
    • Dossiês Informativos
    • Glossário
    • Museu
    • Vídeos
    • MosquitoWeb
  • Comunidade
    • Cooperação e Desenvolvimento
    • Formação
    • Parcerias
  • Contactos
  • Candidaturas
  • pt
    • pt
    • en
Home / Archives for Amaral L

Amaral L

Inhibition of quorum sensing and efflux pump system by trifluoromethyl ketone proton pump inhibitors.

  • Autores: Amaral L, Armada A, Cerca P, Kawase M, Mior Ahmad Subki MA, Molnar J, Motohashi N, Savka MA, Szegedi E, Varga ZG
  • Ano de Publicação: 2012
  • Journal: In vivo
  • Link: http://www.ncbi.nlm.nih.gov/pubmed/?term=Inhibition+of+Quorum+Sensing+and+Efflux+Pump+System+by+Trifluoromethyl+Ketone+Proton+Pump+Inhibitors

BACKGROUND:
One major microbiological problem is the widespread antibiotic resistance. There is an urgent need for new antibiotics and ways to treat multi-drug-resistant infections. Inhibition of bacterial quorum sensing (QS) systems could be an effective alternative in a smuch as they regulate a broad spectrum of cell functions, including, virulence factor production, biofilm organisation and motility. Influx and efflux bacterial systems involved in quorum sensing (QS) are known to depend on the proton motive force (PMF). Thus, a new series of 12 trifluoromethyl ketones (TFs) known to inhibit the PMF, was investigated for effects on the efflux pump of a QS responding bacterium, for its subsequent effect on the response to a QS signal and its direct inhibition of the response to a QS signal.
Ler mais

Activity of fourteen new hydantoin compounds on the human ABCB1 efflux pump.

  • Autores: Amaral L, Armada A, Dymek A, Handzlik J, Kiec-Kononowicz K, Martins A, Molnar J, Spengler G
  • Ano de Publicação: 2012
  • Journal: In vivo
  • Link: http://www.ncbi.nlm.nih.gov/pubmed/?term=Activity+of+Fourteen+New+Hydantoin+Compounds+on+the+Human+ABCB1+Efflux+Pump

BACKGROUND:
Multidrug resistance (MDR) is one of the major concerns in the treatment of cancer and one of the major causes of therapy failure. The overexpression of an ABC transporter, the ABCB1, is often associated with MDR in cancer. Previously it was observed that hydantoin compounds can modulate the activity of the ABCB1 pump.
Ler mais

Screening for efflux pump systems of bacteria by the new acridine orange agar method.

  • Autores: Amaral L, Martins A
  • Ano de Publicação: 2012
  • Journal: In vivo
  • Link: http://www.ncbi.nlm.nih.gov/pubmed/?term=Screening+for+efflux+pump+systems+of+bacteria+by+the+new+acridine+orange+agar+method

AIM:
Development of a non-toxic, fluorescent-based, agar system for the screening of overexpressed bacterial efflux pump systems with common, inexpensive UV accessories.
Ler mais

The activity of 16 new hydantoin compounds on the intrinsic and overexpressed efflux pump system of Staphylococcus aureus.

  • Autores: Amaral L, Armada A, Dymek A, Handzlik J, Kiec-Kononowicz K, Molnar J, Spengler G, Viveiros M
  • Ano de Publicação: 2012
  • Journal: In vivo
  • Link: http://www.ncbi.nlm.nih.gov/pubmed/?term=The+Activity+of+16+New+Hydantoin+Compounds+on+the+Intrinsic+and+Overexpressed+Efflux+Pump+System+of+Staphylococcus+aureus

AIM:
To evaluate a new series of 16 hydantoin derivatives for activity against the intrinsic and overexpressed efflux pumps of the ATTC 25923 Staphylococcus aureus and the clinical Staphylococcus aureus HPV-107 strain, respectively.
Ler mais

Potential therapy of multidrug-resistant and extremely drug-resistant tuberculosis with thioridazine.

  • Autores: Amaral L, Molnar J
  • Ano de Publicação: 2012
  • Journal: In vivo
  • Link: http://www.ncbi.nlm.nih.gov/pubmed/22351663

Multidrug-resistant tuberculosis (MDRTB) infections that continue to increase in frequency globally have progressed to become extremely drug-resistant tuberculosis (XDRTB). The therapeutic problems associated with MDRTB pale in comparison to those for XDRTB where mortality is high.
Ler mais

Contribution of efflux activity to isoniazid resistance in the Mycobacterium tuberculosis complex.

  • Autores: Amaral L, Couto I, Machado D, Rodrigues L, Viveiros M
  • Ano de Publicação: 2012
  • Journal: Genetics and Evolution
  • Link: http://www.ncbi.nlm.nih.gov/pubmed/?term=Contribution+of+efflux+activity+to+isoniazid+resistance+in+the+Mycobacterium+tuberculosis+complex.+Infection

Resistance to isoniazid (INH), one of the main drugs used in tuberculosis (TB) therapy, is mostly due to chromosomal mutations in target genes. However, approximately 20-30% of INH resistant Mycobacterium tuberculosis isolates do not have mutations in any of the genes associated with INH resistance.
Ler mais

Inhibitors of mycobacterial efflux pumps as potential boosters for anti-tubercular drugs.

  • Autores: Ainsa J, Amaral L, Couto I, Machado D, Martins M, Rodrigues L, Viveiros M
  • Ano de Publicação: 2012
  • Journal: Expert Review of Anti-infective Therapy
  • Link: http://www.ncbi.nlm.nih.gov/pubmed/?term=Inhibitors+of+mycobacterial+efflux+pumps+as+potential+boosters+for+anti-tubercular+drugs

Tuberculosis is one of the major causes of infection across the world. The emergence of multi-, extensively- and totally drug-resistant strains of Mycobacterium tuberculosis contributes to the lack of therapeutic options available.
Ler mais

Why and how thioridazine in combination with antibiotics to which the infective strain is resistant will cure totally drug-resistant tuberculosis.

  • Autores: Amaral L, Molnar J
  • Ano de Publicação: 2012
  • Journal: Expert Review of Anti-infective Therapy
  • Link: http://www.ncbi.nlm.nih.gov/pubmed/?term=Why+and+How+Thioridazine+in+combination+with+antibiotics+to+which+the+infective+strain+is+resistant+will+cure+totally+drug+resistant+tuberculosis+(TDR+TB)

Over a period of 14 years, the authors have studied thioridazine, an old neuroleptic, that has been shown to have in vitro activity against intracellular Mycobacterium tuberculosis, regardless of its antibiotic resistance status, thioridazine cures infected mice of antibiotic-susceptible and multidrug-resistant tuberculosis (TB) infections and, when used in combination with antibiotics used for therapy of TB, renders the organism significantly more susceptible.
Ler mais

Evidence of significant synergism between antibiotics and the antipsychotic, antimicrobial drug flupenthixol.

  • Autores: Amaral L, Dasgupta A, Dastidar SG, Jeyaseeli L, Molnar J
  • Ano de Publicação: 2012
  • Journal: European Journal of Clinical Microbiology & Infectious Diseases
  • Link: http://www.ncbi.nlm.nih.gov/pubmed/?term=Evidences+of+Significant+Synergism+between+Antibiotics+and+the+Antipsychotic+Antimicrobial+Drug+Flupenthixol.

Previously, the antipsychotic, non-antibiotic compound flupenthixol dihydrochloride (Fp) was shown to exhibit distinct in vitro antibacterial activity against Gram-positive and Gram-negative bacteria and to significantly protect Swiss albino mice challenged with a known mouse virulent salmonella.
Ler mais

The in vitro activity of products formed from exposure of chlorpromazine to a 266nm laser beam against species of mycobacteria of human interest

  • Autores: Alexandru T, Amaral L, Armada AM, Boni M, Danko B, Dinache A, Hunyadi A, Machado D, Molnar J, Nastasa V, Pascu ML, Ramos J, Viveiros M
  • Ano de Publicação: 2013
  • Journal: In vivo
  • Link: http://www.ncbi.nlm.nih.gov/pubmed/23988894

Chlorpromazine (CPZ) was exposed to a 266 nm laser beam for different periods of time ranging from minutes to 24 h. At intervals, the products from irradiation were evaluated by thin-layer chromatography (TLC) and evaluated for their activity against mycobacteria of human interest (Mycobacterium tuberculosis, M. avium, M. intracellulare and their corresponding reference strains or clinical isolates).
Ler mais

  • « Go to Previous Page
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Go to Next Page »

Footer

INSTITUTO DE HIGIENE E
MEDICINA TROPICAL
UNIVERSIDADE NOVA DE LISBOA
Rua da Junqueira, 100 1349-008 Lisboa
T +351 213 652 600
geral@ihmt.unl.pt

Consulta do Viajante e Medicina Tropical
T +351 213 652 630
T +351 213 652 690
T +351 91 182 37 48
T +351 91 182 44 67
medicina.viagens@ihmt.unl.pt

  • Ensino
  • Investigação
  • Medicina Tropical
  • Cooperação
  • Portal de Denúncias UNL

NOVA University of Lisbon Logo

Siga-nos

  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
  • YouTube

Receber a “newsletter”

© Copyright 2025 IHMT-UNL Todos os Direitos Reservados.
  • Universidade Nova de Lisboa
  • Fundação para a Ciência e a Tecnologia

    UIDB/04413/2020
    UIDP/04413/2020

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok